Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response to Inflammatory Challenge in Major Depressive Disorder
NCT03142919Phase 1Completed
- Start
- Sep 2017
- Primary completion
- Dec 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lipopolysaccharide endotoxin in major depressive disorder (MDD) (4 arms). Primary endpoint: Snaith-Hamilton Pleasure Scale at 2 hours. Started Sep 2017; status: completed.
02
Drugs
lipopolysaccharide endotoxin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03142919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03142919.